JP5717253B2 - 膵島細胞シート、製造方法及びその利用方法 - Google Patents
膵島細胞シート、製造方法及びその利用方法 Download PDFInfo
- Publication number
- JP5717253B2 JP5717253B2 JP2011525883A JP2011525883A JP5717253B2 JP 5717253 B2 JP5717253 B2 JP 5717253B2 JP 2011525883 A JP2011525883 A JP 2011525883A JP 2011525883 A JP2011525883 A JP 2011525883A JP 5717253 B2 JP5717253 B2 JP 5717253B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- islet cell
- cell sheet
- islet
- sheet according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004153 islets of langerhan Anatomy 0.000 title claims description 164
- 238000004519 manufacturing process Methods 0.000 title claims description 22
- 210000004027 cell Anatomy 0.000 claims description 129
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 64
- 238000000034 method Methods 0.000 claims description 36
- 229920000642 polymer Polymers 0.000 claims description 33
- 102000004877 Insulin Human genes 0.000 claims description 32
- 108090001061 Insulin Proteins 0.000 claims description 32
- 229940125396 insulin Drugs 0.000 claims description 32
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 28
- 239000008103 glucose Substances 0.000 claims description 28
- 210000001519 tissue Anatomy 0.000 claims description 28
- 210000004204 blood vessel Anatomy 0.000 claims description 21
- 230000006870 function Effects 0.000 claims description 19
- 210000000496 pancreas Anatomy 0.000 claims description 17
- 238000004113 cell culture Methods 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 14
- 238000011282 treatment Methods 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 210000004748 cultured cell Anatomy 0.000 claims description 12
- 241000700159 Rattus Species 0.000 claims description 11
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims description 10
- 210000003556 vascular endothelial cell Anatomy 0.000 claims description 10
- 230000036571 hydration Effects 0.000 claims description 9
- 238000006703 hydration reaction Methods 0.000 claims description 9
- 230000002792 vascular Effects 0.000 claims description 7
- 230000004203 pancreatic function Effects 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 5
- 230000003511 endothelial effect Effects 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 206010033675 panniculitis Diseases 0.000 claims description 5
- 210000004304 subcutaneous tissue Anatomy 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 102000035195 Peptidases Human genes 0.000 claims description 4
- 210000001185 bone marrow Anatomy 0.000 claims description 4
- 238000007912 intraperitoneal administration Methods 0.000 claims description 4
- 210000000277 pancreatic duct Anatomy 0.000 claims description 4
- 210000004738 parenchymal cell Anatomy 0.000 claims description 4
- 210000000717 sertoli cell Anatomy 0.000 claims description 4
- 210000000130 stem cell Anatomy 0.000 claims description 4
- 102000051325 Glucagon Human genes 0.000 claims description 3
- 108060003199 Glucagon Proteins 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 210000001789 adipocyte Anatomy 0.000 claims description 3
- 210000001612 chondrocyte Anatomy 0.000 claims description 3
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims description 3
- 229960004666 glucagon Drugs 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- 108010028309 kalinin Proteins 0.000 claims description 3
- 241001515942 marmosets Species 0.000 claims description 3
- 210000002747 omentum Anatomy 0.000 claims description 3
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 208000000668 Chronic Pancreatitis Diseases 0.000 claims description 2
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 2
- 206010033649 Pancreatitis chronic Diseases 0.000 claims description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 2
- 210000003494 hepatocyte Anatomy 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims description 2
- 229920005615 natural polymer Polymers 0.000 claims description 2
- 229920001059 synthetic polymer Polymers 0.000 claims description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 2
- 238000004299 exfoliation Methods 0.000 claims 2
- 241000700199 Cavia porcellus Species 0.000 claims 1
- 241000282577 Pan troglodytes Species 0.000 claims 1
- 241000009328 Perro Species 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 230000003915 cell function Effects 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 230000003908 liver function Effects 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 239000000758 substrate Substances 0.000 description 32
- 206010012601 diabetes mellitus Diseases 0.000 description 31
- 238000002054 transplantation Methods 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 25
- 239000008280 blood Substances 0.000 description 25
- 238000011579 SCID mouse model Methods 0.000 description 24
- 229920000208 temperature-responsive polymer Polymers 0.000 description 16
- 238000010186 staining Methods 0.000 description 14
- 238000000576 coating method Methods 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 10
- 239000011557 critical solution Substances 0.000 description 9
- 210000004379 membrane Anatomy 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 7
- 229960001052 streptozocin Drugs 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000012894 fetal calf serum Substances 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 5
- -1 acrylamide compound Chemical class 0.000 description 5
- 210000001047 desmosome Anatomy 0.000 description 5
- 238000003475 lamination Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000007334 copolymerization reaction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000005228 liver tissue Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 241000282579 Pan Species 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- 230000004956 cell adhesive effect Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 108010007093 dispase Proteins 0.000 description 3
- 210000003195 fascia Anatomy 0.000 description 3
- 238000007446 glucose tolerance test Methods 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 238000011694 lewis rat Methods 0.000 description 3
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 102000018886 Pancreatic Polypeptide Human genes 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 210000003890 endocrine cell Anatomy 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000000569 greater omentum Anatomy 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 210000003240 portal vein Anatomy 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- YQIGLEFUZMIVHU-UHFFFAOYSA-N 2-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C(C)=C YQIGLEFUZMIVHU-UHFFFAOYSA-N 0.000 description 1
- HFDKKNHCYWNNNQ-YOGANYHLSA-N 75976-10-2 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 HFDKKNHCYWNNNQ-YOGANYHLSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229920001688 coating polymer Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 210000003499 exocrine gland Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- LCXIFAOALNZGDO-UHFFFAOYSA-N n-cyclopropylprop-2-enamide Chemical compound C=CC(=O)NC1CC1 LCXIFAOALNZGDO-UHFFFAOYSA-N 0.000 description 1
- 235000020925 non fasting Nutrition 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 210000002325 somatostatin-secreting cell Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000007847 structural defect Effects 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 238000002689 xenotransplantation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2539/00—Supports and/or coatings for cell culture characterised by properties
- C12N2539/10—Coating allowing for selective detachment of cells, e.g. thermoreactive coating
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011525883A JP5717253B2 (ja) | 2009-08-02 | 2010-08-02 | 膵島細胞シート、製造方法及びその利用方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009193648 | 2009-08-02 | ||
| JP2009193648 | 2009-08-02 | ||
| JP2011525883A JP5717253B2 (ja) | 2009-08-02 | 2010-08-02 | 膵島細胞シート、製造方法及びその利用方法 |
| PCT/JP2010/063033 WO2011016423A1 (ja) | 2009-08-02 | 2010-08-02 | 膵島細胞シート、製造方法及びその利用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2011016423A1 JPWO2011016423A1 (ja) | 2013-01-10 |
| JP5717253B2 true JP5717253B2 (ja) | 2015-05-13 |
Family
ID=43544318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011525883A Expired - Fee Related JP5717253B2 (ja) | 2009-08-02 | 2010-08-02 | 膵島細胞シート、製造方法及びその利用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20120210451A1 (enExample) |
| EP (1) | EP2491957A4 (enExample) |
| JP (1) | JP5717253B2 (enExample) |
| CN (1) | CN102858380B (enExample) |
| CA (1) | CA2769852A1 (enExample) |
| IN (1) | IN2012DN01268A (enExample) |
| WO (1) | WO2011016423A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004070023A1 (ja) * | 2003-02-06 | 2004-08-19 | Cellseed Inc. | 前眼部関連細胞シート、３次元構造体、及びそれらの製造法 |
| JP4335873B2 (ja) * | 2003-02-20 | 2009-09-30 | 株式会社セルシード | 再生角膜内皮細胞シート、製造方法及びその利用方法 |
| JP4827729B2 (ja) * | 2004-04-25 | 2011-11-30 | 株式会社セルシード | 培養歯根膜細胞シート、製造方法及びその利用方法 |
| JP4921353B2 (ja) * | 2005-02-28 | 2012-04-25 | 株式会社セルシード | 培養細胞シート、製造方法及びその利用方法 |
| JPWO2006093153A1 (ja) | 2005-02-28 | 2008-08-07 | 株式会社セルシード | 培養細胞シート、製造方法及びその利用した組織修復方法 |
| US9598668B2 (en) * | 2008-10-14 | 2017-03-21 | Cellseed Inc. | Temperature-responsive cell culture substrate and method for producing the same |
| WO2012118099A1 (ja) * | 2011-02-28 | 2012-09-07 | 学校法人 東京女子医科大学 | サイトカイン産生細胞シートとその利用方法 |
| JP2012205516A (ja) | 2011-03-29 | 2012-10-25 | Osaka Univ | 人工皮膚モデルの製造方法、及び人工皮膚モデル |
| SG194151A1 (en) * | 2011-04-08 | 2013-11-29 | Otsuka Pharma Co Ltd | Method for producing sheet-like pancreatic islet |
| JP6189291B2 (ja) | 2012-05-25 | 2017-08-30 | 学校法人東京女子医科大学 | 物質の濡れ性評価法 |
| US20150250925A1 (en) * | 2012-09-04 | 2015-09-10 | Biomedical Technology Hybrid Co., Ltd. | Artificial skin tissue, artificial skin model and manufacturing method therefor |
| CN105555950B (zh) * | 2013-06-13 | 2021-03-05 | 奥尔吉尼西丝有限公司 | 细胞群体、转分化的方法及其使用方法 |
| WO2015159889A1 (ja) * | 2014-04-14 | 2015-10-22 | 学校法人福岡大学 | インスリン産生細胞移植方法 |
| MA41296A (fr) | 2014-12-30 | 2017-11-07 | Orgenesis Ltd | Procédés de transdifférenciation et procédés d'utilisation de ceux-ci |
| EP3313976A4 (en) * | 2015-06-25 | 2019-02-20 | Auckland Uniservices Limited | TISSUE CULTURE DEVICE AND METHOD |
| EP3315596A4 (en) * | 2015-06-26 | 2019-02-13 | National Cerebral and Cardiovascular Center | CELL CULTURE CONTAINER |
| KR101828696B1 (ko) * | 2015-08-26 | 2018-02-12 | 울산대학교 산학협력단 | 인슐린분비세포 이식용 조성물 및 이의 제조방법 |
| JP6593589B2 (ja) * | 2015-09-30 | 2019-10-23 | 澁谷工業株式会社 | 細胞塊シートの作製方法および細胞塊シート |
| US20170304528A1 (en) * | 2016-04-22 | 2017-10-26 | DeepScience Ltd. | Implantable medical device for delivering cells |
| SG11201911256UA (en) | 2017-05-08 | 2020-01-30 | Orgenesis Ltd | Transdifferentiated cell populations and methods of use thereof |
| TWI875793B (zh) * | 2019-08-08 | 2025-03-11 | 學校法人 東京女子醫科大學 | 創傷被覆用片及創傷被覆方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05168470A (ja) * | 1990-08-08 | 1993-07-02 | W R Grace & Co | 複数の細胞種からなる細胞塊状体とシートおよびその製造法 |
| WO1997028252A1 (en) * | 1996-01-31 | 1997-08-07 | Vivorx Pharmaceuticals, Inc. | Process for aggregating cells and forming sheets of mammalian tissue in a horizontally rotating bioreactor |
| WO2004091679A1 (ja) * | 2003-04-16 | 2004-10-28 | Creative Co., Ltd. | 細胞製剤 |
| JP2006519865A (ja) * | 2003-03-07 | 2006-08-31 | エイセル， インコーポレイテッド | 組織の修復および器官欠損の処置のための脱細胞化された肝臓 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06104061B2 (ja) | 1989-02-10 | 1994-12-21 | 花王株式会社 | 細胞培養支持体材料 |
| EP0470681A3 (en) * | 1990-08-08 | 1992-04-22 | W.R. Grace & Co.-Conn. | Cell clusters or sheets comprising a plurality of cell species and preparations thereof |
| JPH05192138A (ja) | 1992-01-22 | 1993-08-03 | Kao Corp | 皮膚細胞培養法及び培養皮膚 |
| WO2000014542A2 (de) * | 1998-09-08 | 2000-03-16 | Privates Institut Bioserv Gmbh | Diagnostisches verfahren zur erkennung einer pankreasfunktionsstörung |
| JP4567936B2 (ja) * | 2000-03-16 | 2010-10-27 | 株式会社セルシード | 細胞培養用支持体材料、細胞の共培養方法およびそれより得られる共培養細胞シート |
| AU2002360424A1 (en) * | 2001-11-26 | 2003-06-10 | Advanced Cell Technology, Inc. | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| WO2003083064A2 (en) * | 2002-03-25 | 2003-10-09 | Washington University | Chimeric pancreas |
| JP4335873B2 (ja) * | 2003-02-20 | 2009-09-30 | 株式会社セルシード | 再生角膜内皮細胞シート、製造方法及びその利用方法 |
| JP2006304791A (ja) | 2005-03-31 | 2006-11-09 | National Institute For Materials Science | 三次元培養装置を用いた細胞集塊の大量形成法 |
| ES2561944T3 (es) | 2006-01-12 | 2016-03-01 | Tokyo Women's Medical University | Procedimiento para mantener la función de las células de tejido hepático durante un tiempo prolongado |
| KR100788800B1 (ko) * | 2006-06-26 | 2007-12-27 | 이정익 | 자가 탄성연골로 캡슐화된 이식물 및 이의 제조방법 |
| CN101147704A (zh) * | 2006-09-18 | 2008-03-26 | 中国人民解放军军事医学科学院野战输血研究所 | 一种可移植的人工替代单元 |
| US20100272697A1 (en) * | 2007-04-10 | 2010-10-28 | Ali Naji | Pancreatic islet cells composition and methods |
| JP2008278769A (ja) | 2007-05-08 | 2008-11-20 | Hokkaido Univ | 膵島細胞からなる３次元凝集体をインビトロで製造する方法 |
-
2010
- 2010-08-02 EP EP10806422.1A patent/EP2491957A4/en not_active Withdrawn
- 2010-08-02 JP JP2011525883A patent/JP5717253B2/ja not_active Expired - Fee Related
- 2010-08-02 IN IN1268DEN2012 patent/IN2012DN01268A/en unknown
- 2010-08-02 WO PCT/JP2010/063033 patent/WO2011016423A1/ja not_active Ceased
- 2010-08-02 CA CA2769852A patent/CA2769852A1/en not_active Abandoned
- 2010-08-02 CN CN201080044395.5A patent/CN102858380B/zh not_active Expired - Fee Related
- 2010-08-02 US US13/388,535 patent/US20120210451A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05168470A (ja) * | 1990-08-08 | 1993-07-02 | W R Grace & Co | 複数の細胞種からなる細胞塊状体とシートおよびその製造法 |
| WO1997028252A1 (en) * | 1996-01-31 | 1997-08-07 | Vivorx Pharmaceuticals, Inc. | Process for aggregating cells and forming sheets of mammalian tissue in a horizontally rotating bioreactor |
| JP2006519865A (ja) * | 2003-03-07 | 2006-08-31 | エイセル， インコーポレイテッド | 組織の修復および器官欠損の処置のための脱細胞化された肝臓 |
| WO2004091679A1 (ja) * | 2003-04-16 | 2004-10-28 | Creative Co., Ltd. | 細胞製剤 |
Non-Patent Citations (6)
| Title |
|---|
| JPN6010059608; 李 禎翼ら: '温度応答性の培養皿を用いた細胞シート工学法による免疫隔離人工膵の開発' Ｔｉｓｓ． Ｃｕｌｔ． Ｒｅｓ． Ｃｏｍｍｕｎ． Ｖｏｌ．２６, 2007, ｐ．１１５-１２３ * |
| JPN6010059610; 清水裕史ら: '温度応答性培養皿を用いた機能的膵島細胞シートの構築' 再生医療 Ｖｏｌ．８， Ｓｕｐｐｌ, 20090205, ｐ．１５３ * |
| JPN6014036435; Ｂｉｏｍａｔｅｒｉａｌｓ Ｖｏｌ．２５, 2004, ｐ．５８８５-５８９２ * |
| JPN6014036436; 蛋白質 核酸 酵素 Ｖｏｌ．４５， Ｎｏ．１０, 2000, ｐ．７２-７８ * |
| JPN6014036437; 移植 Ｖｏｌ．４３， Ｎｏ．２, 2008, ｐ．１２５-１３１ * |
| JPN6014036438; 医学のあゆみ Ｖｏｌ．２２９， Ｎｏ．９, 20090530, ｐ．７４８-７５２ * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2491957A4 (en) | 2013-10-02 |
| IN2012DN01268A (enExample) | 2015-05-15 |
| JPWO2011016423A1 (ja) | 2013-01-10 |
| CA2769852A1 (en) | 2011-02-10 |
| EP2491957A1 (en) | 2012-08-29 |
| CN102858380B (zh) | 2016-03-23 |
| WO2011016423A1 (ja) | 2011-02-10 |
| US20120210451A1 (en) | 2012-08-16 |
| CN102858380A (zh) | 2013-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5717253B2 (ja) | 膵島細胞シート、製造方法及びその利用方法 | |
| Shimizu et al. | Bioengineering of a functional sheet of islet cells for the treatment of diabetes mellitus | |
| Yamato et al. | Temperature-responsive cell culture surfaces for regenerative medicine with cell sheet engineering | |
| US20240360408A1 (en) | Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs | |
| US20130173018A1 (en) | Method for manufacturing multilayered cell sheet, multilayered cell sheet having vascular network obtained thereby, and method of use thereof | |
| Jeong et al. | Immune-protected xenogeneic bioartificial livers with liver-specific microarchitecture and hydrogel-encapsulated cells | |
| JP2017074050A (ja) | 肝組織細胞機能の長期維持方法 | |
| Kim et al. | Cell sheet tissue engineering for scaffold-free three-dimensional (3D) tissue reconstruction | |
| US20170035939A1 (en) | Adipocyte sheet, three-dimensional structure thereof, and method for producing the same | |
| EP3315601B1 (en) | Method for culturing animal cell composition, method for producing animal cell composition using same, and animal cell composition | |
| JP5263756B2 (ja) | 細胞の培養方法および細胞培養物 | |
| Kobayashi et al. | Design of temperature-responsive cell culture surfaces for cell sheet-based regenerative therapy and 3D tissue fabrication | |
| JP2022527949A (ja) | 治療用ハイドロゲルデバイス | |
| JPWO2005047496A1 (ja) | 細胞培養法、細胞の三次元培養法、三次元組織、人工臓器、及び組織移植方法 | |
| Sukhikh et al. | Stem cell transplantation for treatment of liver diseases: from biological foundations to clinical experience | |
| US20100015198A1 (en) | Transplants encapsulated with self-elastic cartilage and method of preparing the same | |
| RU2586952C1 (ru) | Способ лечения печеночной недостаточности | |
| Lojudice¹ et al. | Medicine of Endocrine Pancreas | |
| WO2011122318A1 (ja) | 治療用移植材料及びその利用方法 | |
| RU2618989C1 (ru) | Способ лечения печеночной недостаточности | |
| Nagata et al. | 3D Hepatic Tissue Formed by iPSC-Derived Hepatocytes Using a Cell Fiber Technology | |
| Tomonaga et al. | Rat hepatocyte spheroids formed on temperature-responsive PIPAAm polymergrafted surface maintain long-term differentiated hepatocyte function | |
| Tissue | VI. How to Create an Artificial Heart Ex Vivo? | |
| GERMAIN et al. | The self-assembly as a novel approach to tissue-engineering | |
| as Scaffolds | 10 Supermacroporous |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130725 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140827 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141027 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150212 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150313 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5717253 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |